Belvedere Trading LLC Anavex Life Sciences Corp. Transaction History
Belvedere Trading LLC
- $82.2 Billion
- Q4 2024
A detailed history of Belvedere Trading LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Belvedere Trading LLC holds 23,000 shares of AVXL stock, worth $199,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,000
Previous 23,000
-0.0%
Holding current value
$199,410
Previous $130,000
90.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
188Shares Held
29.2MCall Options Held
894KPut Options Held
821K-
Black Rock Inc. New York, NY6.39MShares$55.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$40.6 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$20.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$16.3 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.13MShares$9.84 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $676M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...